Novel platform could lead to new Lundbeck drugs
![Foto: Colourbox](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article4933748.ece/ALTERNATES/schema-16_9/mus.jpg)
From mice to cells, and from cells to humans – that is the route Danish pharma outfit Lundbeck will travel in an effort to discover the next breakthrough in schizophrenia treatment.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Diamond in the rough in Lundbeck’s pipeline
For abonnenter
Lundbeck closing in on schizophrenia mystery
For abonnenter
Schizofrenia drug from Lundbeck approved by the FDA
For abonnenter